Matches in SemOpenAlex for { <https://semopenalex.org/work/W2270292397> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2270292397 endingPage "483" @default.
- W2270292397 startingPage "479" @default.
- W2270292397 abstract "The SILVER (Study of Irbesartan in Left VEntricular hypertrophy Regression) trial is designed to test the hypothesis that the newly developed angiontensin-II receptor antagonist, irbesartan, will produce a greater reduction in left ventricular (LV) mass than felodipine ER, in a population of hypertensive patients defined by seated diastolic blood pressure (SeDBP) in the range 95-115 mmHg or seated systolic blood pressure (SeSBP) in the range 160-200 mm Hg. A population of 360 men and women of non-childbearing potential, >18 years of age, with hypertension, newly diagnosed or after a 3-week washout from previous anti-hypertensive or vasodilator therapies, will be randomised at approximately 80-90 European sites. Add-on therapy with hydrochlorothiazide and atenolol will be allowed for blood pressure control. Patients will be studied by two-dimensional and M-mode echocardiography at baseline (central validation of LV hypertrophy), on randomisation day, and after 6 and 12 months randomised therapy. Blinded analysis of echocardiograms will be performed at a central laboratory, which will provide measurements of the LV mass index (LVMI), determined by M-mode readings according to Devereux formula and using the Penn convention. The primary end-point of the study will be the change in LVMI from baseline to 12 months. The study power is 90% to detect differences between groups from baseline of approximately 8 g/m2." @default.
- W2270292397 created "2016-06-24" @default.
- W2270292397 creator A5001569554 @default.
- W2270292397 creator A5001576130 @default.
- W2270292397 creator A5011073019 @default.
- W2270292397 creator A5017971948 @default.
- W2270292397 creator A5025665346 @default.
- W2270292397 creator A5029850259 @default.
- W2270292397 creator A5037618935 @default.
- W2270292397 creator A5047185061 @default.
- W2270292397 creator A5056706626 @default.
- W2270292397 date "1998-07-01" @default.
- W2270292397 modified "2023-09-24" @default.
- W2270292397 title "Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (The SILVER trial)" @default.
- W2270292397 doi "https://doi.org/10.1038/sj.jhh.1000621" @default.
- W2270292397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9702935" @default.
- W2270292397 hasPublicationYear "1998" @default.
- W2270292397 type Work @default.
- W2270292397 sameAs 2270292397 @default.
- W2270292397 citedByCount "8" @default.
- W2270292397 crossrefType "journal-article" @default.
- W2270292397 hasAuthorship W2270292397A5001569554 @default.
- W2270292397 hasAuthorship W2270292397A5001576130 @default.
- W2270292397 hasAuthorship W2270292397A5011073019 @default.
- W2270292397 hasAuthorship W2270292397A5017971948 @default.
- W2270292397 hasAuthorship W2270292397A5025665346 @default.
- W2270292397 hasAuthorship W2270292397A5029850259 @default.
- W2270292397 hasAuthorship W2270292397A5037618935 @default.
- W2270292397 hasAuthorship W2270292397A5047185061 @default.
- W2270292397 hasAuthorship W2270292397A5056706626 @default.
- W2270292397 hasBestOaLocation W22702923971 @default.
- W2270292397 hasConcept C126322002 @default.
- W2270292397 hasConcept C142724271 @default.
- W2270292397 hasConcept C164705383 @default.
- W2270292397 hasConcept C167414201 @default.
- W2270292397 hasConcept C204787440 @default.
- W2270292397 hasConcept C27081682 @default.
- W2270292397 hasConcept C2776002628 @default.
- W2270292397 hasConcept C2776525901 @default.
- W2270292397 hasConcept C2780259554 @default.
- W2270292397 hasConcept C2780361556 @default.
- W2270292397 hasConcept C2780648877 @default.
- W2270292397 hasConcept C2908647359 @default.
- W2270292397 hasConcept C57900726 @default.
- W2270292397 hasConcept C71924100 @default.
- W2270292397 hasConcept C84393581 @default.
- W2270292397 hasConcept C99454951 @default.
- W2270292397 hasConceptScore W2270292397C126322002 @default.
- W2270292397 hasConceptScore W2270292397C142724271 @default.
- W2270292397 hasConceptScore W2270292397C164705383 @default.
- W2270292397 hasConceptScore W2270292397C167414201 @default.
- W2270292397 hasConceptScore W2270292397C204787440 @default.
- W2270292397 hasConceptScore W2270292397C27081682 @default.
- W2270292397 hasConceptScore W2270292397C2776002628 @default.
- W2270292397 hasConceptScore W2270292397C2776525901 @default.
- W2270292397 hasConceptScore W2270292397C2780259554 @default.
- W2270292397 hasConceptScore W2270292397C2780361556 @default.
- W2270292397 hasConceptScore W2270292397C2780648877 @default.
- W2270292397 hasConceptScore W2270292397C2908647359 @default.
- W2270292397 hasConceptScore W2270292397C57900726 @default.
- W2270292397 hasConceptScore W2270292397C71924100 @default.
- W2270292397 hasConceptScore W2270292397C84393581 @default.
- W2270292397 hasConceptScore W2270292397C99454951 @default.
- W2270292397 hasIssue "7" @default.
- W2270292397 hasLocation W22702923971 @default.
- W2270292397 hasLocation W22702923972 @default.
- W2270292397 hasOpenAccess W2270292397 @default.
- W2270292397 hasPrimaryLocation W22702923971 @default.
- W2270292397 hasRelatedWork W2009780085 @default.
- W2270292397 hasRelatedWork W2033439327 @default.
- W2270292397 hasRelatedWork W2051386828 @default.
- W2270292397 hasRelatedWork W2054035451 @default.
- W2270292397 hasRelatedWork W2082271157 @default.
- W2270292397 hasRelatedWork W2090362677 @default.
- W2270292397 hasRelatedWork W2112824791 @default.
- W2270292397 hasRelatedWork W2270292397 @default.
- W2270292397 hasRelatedWork W2415054319 @default.
- W2270292397 hasRelatedWork W3031137618 @default.
- W2270292397 hasVolume "12" @default.
- W2270292397 isParatext "false" @default.
- W2270292397 isRetracted "false" @default.
- W2270292397 magId "2270292397" @default.
- W2270292397 workType "article" @default.